Novel Design of Nonpeptide AVP V<sub>2</sub>Receptor Agonists:  Structural Requirements for an Agonist Having 1-(4-Aminobenzoyl)-2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepine as a Template

Kazumi Kondo, Hidenori Ogawa, Tomoichi Shinohara, Muneaki Kurimura, Yoshihisa Tanada, Keizo Kan, Hiroshi Yamashita, Shigeki Nakamura, Takahiro Hirano, Yoshitaka Yamamura,

Journal of Medicinal Chemistry · 2000 · 63 citations · 27 references

DOIFull text

Open access

Concepts

Abstract

The discovery of a series of nonpeptide arginine vasopressin V(2) receptor agonists is described. After identifying the aniline derivative 8 as our lead compound from the metabolites of compound 7 that showed antidiuretic activity by po administration to Brattleboro rats, improvements in the in vitro potency involving evaluations of the structural requirements for agonist action and optimizing the structure of the benzoyl moiety have been intensively undertaken. These studies led to compounds 16g, 19a, and 23b,h,i that show potent agonist activity for the V(2) receptor.

References

27